Topic

All

8
Nov
2026

The Best AI Health Innovators Have a Feel for People

Abba Eban observed in 1967 that wisdom tends to arrive only after all other alternatives have been exhausted. Happily, some of the most thoughtful innovators in AI and health seem to be getting there. Over the last several weeks I’ve had an unusual opportunity to speak before and engage with audiences of investment bankers, investors, operators, and even political scientists,...
Read More
31
Oct
2026

AI and Tocqueville at Harvard

I found myself this week back on my undergraduate campus, giving a seminar about “AI, Health, and Agency” for, of all things, Harvard’s Program in Constitutional Government, invited by Professor (emeritus) Harvey C. Mansfield, who at 94, remains sharper than most of us are or likely ever were. He is not only one of the university’s most distinguished scholars, but...
Read More
23
Sep
2026

Long-Lasting Antibodies for Immune Diseases: Cameron Turtle on The Long Run

Cameron Turtle is today’s guest on The Long Run. Cameron is the CEO of Waltham, Mass.-based Spyre Therapeutics. The company is developing antibody drug candidates that are engineered to be longer-lasting than today’s drugs for immune disorders. This means patients could take fewer injections and the drugs should stay stable in the bloodstream to keep the disease under control longer....
Read More
9
Sep
2026

Drugs That Go Where None Could Before: Mathai Mammen on The Long Run

Mathai Mammen is today’s guest on The Long Run. Mathai is the CEO of Cambridge, Mass.-based Parabilis Medicines. The company has a platform for making drugs that hit elusive biological targets known as drivers of disease. Parabilis attacks them with alpha-helical peptide drug candidates that can get inside cells and bind with relatively flat and smooth surfaces of proteins. It...
Read More
3
Sep
2026

IYKYK: Leave the Vortex, Take the Influence

It’s not just your kids who aspire to become influencers. Attracting attention –- often through provocative content delivered through social media at high volume –- can seem increasingly like a business imperative, as the a16z co-founders have described (here, here) and, in the case of Andreessen, unhesitatingly embraced. The Attention Imperative But they’re not alone; many physicians, researchers, and policy...
Read More
1 2 3 … 87